Decreased Prevalence of Rheumatic Heart Disease Confirmed Among HIV-positive Youth.


Journal

The Pediatric infectious disease journal
ISSN: 1532-0987
Titre abrégé: Pediatr Infect Dis J
Pays: United States
ID NLM: 8701858

Informations de publication

Date de publication:
04 2019
Historique:
entrez: 19 3 2019
pubmed: 19 3 2019
medline: 19 3 2020
Statut: ppublish

Résumé

There is geographical overlap between areas endemic for rheumatic heart disease (RHD) and those endemic for HIV. A recent pilot study demonstrated that children living with HIV might be at less risk for RHD development; however, the sample size was too small to make definitive conclusions. Our objective was to determine the prevalence of RHD among HIV-positive children in Uganda. We conducted a prospective, cross-sectional study of HIV-positive children (5-15 years of age) receiving care at the Baylor Uganda HIV Clinic, Kampala, Uganda. A focused echocardiogram and chart review was performed. A sample size of 988 children was needed to provide 80% power to detect a difference in population prevalence between HIV-positive children and the general population, 2.97% [95% confidence interval (CI): 2.70-3.24%], based on previous reports. Screening echocardiography of 993 HIV-positive children found 15 individuals (1.5%; 95% CI: 0.88%-2.54%) with RHD. Of these 15, 2 were classified as definite RHD and 13 as borderline RHD. The majority of children had isolated mitral valve disease (93%). Children found to have RHD were older than those without RHD, 12 versus 10 years of age (P = 0.004). When separated based on geographic location, the prevalence of RHD among HIV-positive children from Kampala was 1.28% (95% CI: 0.63%-2.51%) compared with 2.1% (95% CI: 0.89%-4.89%) in those from outside Kampala. Children living with HIV have a lower prevalence of RHD than the general pediatric population. Further studies are needed to explore this protective association.

Sections du résumé

BACKGROUND
There is geographical overlap between areas endemic for rheumatic heart disease (RHD) and those endemic for HIV. A recent pilot study demonstrated that children living with HIV might be at less risk for RHD development; however, the sample size was too small to make definitive conclusions. Our objective was to determine the prevalence of RHD among HIV-positive children in Uganda.
METHODS
We conducted a prospective, cross-sectional study of HIV-positive children (5-15 years of age) receiving care at the Baylor Uganda HIV Clinic, Kampala, Uganda. A focused echocardiogram and chart review was performed. A sample size of 988 children was needed to provide 80% power to detect a difference in population prevalence between HIV-positive children and the general population, 2.97% [95% confidence interval (CI): 2.70-3.24%], based on previous reports.
RESULTS
Screening echocardiography of 993 HIV-positive children found 15 individuals (1.5%; 95% CI: 0.88%-2.54%) with RHD. Of these 15, 2 were classified as definite RHD and 13 as borderline RHD. The majority of children had isolated mitral valve disease (93%). Children found to have RHD were older than those without RHD, 12 versus 10 years of age (P = 0.004). When separated based on geographic location, the prevalence of RHD among HIV-positive children from Kampala was 1.28% (95% CI: 0.63%-2.51%) compared with 2.1% (95% CI: 0.89%-4.89%) in those from outside Kampala.
CONCLUSIONS
Children living with HIV have a lower prevalence of RHD than the general pediatric population. Further studies are needed to explore this protective association.

Identifiants

pubmed: 30882733
doi: 10.1097/INF.0000000000002161
pii: 00006454-201904000-00014
pmc: PMC6355385
mid: NIHMS1502180
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

406-409

Subventions

Organisme : NHLBI NIH HHS
ID : K23 HL123341
Pays : United States

Références

Afr Health Sci. 2015 Dec;15(4):1182-8
pubmed: 26958019
Eur Heart J Cardiovasc Imaging. 2015 May;16(5):475-82
pubmed: 25564396
J Acquir Immune Defic Syndr. 2016 Feb 1;71(2):196-9
pubmed: 26413847
Nat Rev Cardiol. 2012 Feb 28;9(5):297-309
pubmed: 22371105
Nat Rev Cardiol. 2013 May;10(5):284-92
pubmed: 23546444
Circulation. 2014 May 13;129(19):1953-61
pubmed: 24622384
Int J Cardiol. 2016 Jan 1;202:238-9
pubmed: 26402451
J Am Soc Echocardiogr. 2016 Mar;29(3):253-8
pubmed: 26725186
J Clin Microbiol. 2012 Dec;50(12):4067-72
pubmed: 23052313
J Clin Epidemiol. 1992 Aug;45(8):871-5
pubmed: 1624969
Pediatr Cardiol. 2014 Oct;35(7):1259-67
pubmed: 24827080
N Engl J Med. 2017 Aug 24;377(8):713-722
pubmed: 28834488
Circulation. 2012 Jun 26;125(25):3127-32
pubmed: 22626741
EBioMedicine. 2016 Feb 06;5:161-6
pubmed: 27077123
Medicine (Baltimore). 2017 Jan;96(4):e5769
pubmed: 28121924
Rheum Dis Clin North Am. 1991 Feb;17(1):177-88
pubmed: 2041886
Autoimmun Rev. 2002 Dec;1(6):329-37
pubmed: 12848988
PLoS One. 2012;7(8):e43917
pubmed: 22952810

Auteurs

Ian W Hovis (IW)

From the Children's National Health System, Washington, District of Columbia.

Judith Namuyonga (J)

Uganda Heart Institute.

Grace P Kisitu (GP)

Baylor College of Medicine Children's Foundation, Mulago Hospital, Kampala, Uganda.

Emma Ndagire (E)

Uganda Heart Institute.

Emmy Okello (E)

Uganda Heart Institute.

Chris T Longenecker (CT)

Case Western Reserve University School of Medicine, Cleveland, Ohio.

Amy Sanyahumbi (A)

Baylor College of Medicine, Texas Children's Hospital, Houston, Texas.

Craig A Sable (CA)

From the Children's National Health System, Washington, District of Columbia.

Daniel J Penny (DJ)

Baylor College of Medicine, Texas Children's Hospital, Houston, Texas.

Peter Lwabi (P)

Uganda Heart Institute.

Adeodata R Kekitiinwa (AR)

Baylor College of Medicine Children's Foundation, Mulago Hospital, Kampala, Uganda.

Andrea Beaton (A)

From the Children's National Health System, Washington, District of Columbia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH